Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.08x is 24% below its 5-year average of -0.87x, near the high end of its 5-year range (-20.92x–1.96x).
847.85% below its 12-month average of -0.11x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-07-31): 1.96x.
INTEREST COVERAGE RATIO
-1.08x
INTEREST COVERAGE RATIO AVG TTM
-0.11x
INTEREST COVERAGE RATIO AVG 3Y
0.72x
INTEREST COVERAGE RATIO AVG 5Y
-0.87x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-847.85%
CURRENT VS 3Y AVG
-249.77%
CURRENT VS 5Y AVG
-23.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+81.35%
vs the sector median at left
High Tide Inc.
Market Cap
$236.81M
Interest Coverage Ratio
-1.08x
TTM Avg
-0.11x
3Y Avg
0.72x
5Y Avg
-0.87x
Market Cap
$236.33M
Interest Coverage Ratio
N/A
TTM Avg
28.01x
3Y Avg
25.48x
5Y Avg
25.48x
Market Cap
$237.27M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$237.88M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.34M
Interest Coverage Ratio
N/A
TTM Avg
0.97x
3Y Avg
1.45x
5Y Avg
67.07x
Market Cap
$232.96M
Interest Coverage Ratio
-8.56x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.38M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $236.81M | -1.08x | -0.11x | 0.72x | -0.87x |
| SIGA Technologies, Inc. (SIGA)vs › | $236.33M | N/A | 28.01x | 25.48x | 25.48x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.27M | 0.97x | 0.97x | 0.97x | 0.97x |
| InflaRx N.V. (IFRX)vs › | $237.88M | -1280.37x | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.34M | N/A | 0.97x | 1.45x | 67.07x |
| Invivyd, Inc. (IVVD)vs › | $236.60M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $232.96M | -8.56x | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $240.70M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $240.38M | -2.74x | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | 0.57x | 0.57x | 0.57x | 0.57x |
Interest Coverage
-1.1x
Debt/Equity
1.17
Current Ratio
1.50
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-07-31 | 1.96x |
| 2026-04-30 | 1.61x |
| 2026-01-31 | 0.84x |
| 2025-10-31 | -6.48x |
| 2025-07-31 | 1.51x |
| 2025-04-30 | 0.27x |
| 2025-01-31 | 0.02x |
| 2024-10-31 | -0.72x |
| 2024-07-31 | 0.98x |
| 2024-04-30 | 0.70x |
| 2024-01-31 | 0.96x |
| 2023-12-29 | -12.74x |
| 2023-07-31 | -0.20x |
| 2023-04-30 | -0.91x |
| 2023-01-31 | -1.41x |
| 2022-10-31 | -20.92x |
| 2022-07-31 | -2.11x |
| 2022-04-30 | -3.16x |
| 2022-01-31 | -2.53x |
| 2021-10-31 | -3.14x |
| 2021-07-31 | -4.80x |
| 2021-04-30 | -1.46x |
| 2021-01-31 | -0.70x |
| 2020-10-31 | 0.63x |
| 2020-07-31 | 0.62x |
| 2020-04-30 | 0.06x |
| 2020-01-31 | -1.13x |
| 2019-10-31 | -3.71x |
| 2019-07-31 | -3.72x |
| 2019-04-30 | -14.27x |
| 2019-01-31 | -38.20x |
| 2018-10-31 | -74.98x |
| 2018-07-31 | -11.78x |
| 2018-04-30 | -22.53x |
| 2018-01-31 | 31.93x |
